Heparin and its low molecular weight derivatives: anticoagulant and antithrombotic properties

scientific article published in January 1986

Heparin and its low molecular weight derivatives: anticoagulant and antithrombotic properties is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1159/000215348
P698PubMed publication ID3744129

P2093author name stringBergqvist D
Lindahl U
Holmer E
Söderberg K
P921main subjectanticoagulationQ63279445
heparinQ190016
anticoagulantQ215118
P304page(s)1-7
P577publication date1986-01-01
P1433published inPathophysiology of Haemostasis and Thrombosis: international journal on haemostasis and thrombosis researchQ15758753
P1476titleHeparin and its low molecular weight derivatives: anticoagulant and antithrombotic properties
P478volume16 Suppl 2

Reverse relations

cites work (P2860)
Q41139783Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders
Q33993713Dalteparin: an update of its pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic disease
Q70058022Heparin and heparinoids impair adrenaline and platelet-activating factor but not thrombin-induced inhibition of adenylate cyclase and stimulation of GTP hydrolysis in human platelet membranes
Q28318388Heparin pharmacokinetics and pharmacodynamics
Q46590436Low molecular weight heparin: how does it modify lipid metabolism in chronic hemodialysis patients?
Q39213540New Anticoagulants for the Prevention and Treatment of Venous Thromboembolism
Q33892529Outpatient Therapy of Deep Vein Thrombosis
Q33399576Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Q37827836Prophylaxis of venous thromboembolism
Q50291215SERPINC1 binds SERPINC1 activators

Search more.